Meet Our Faculty

Kirk Deitsch

Kirk Deitsch, Ph.D.

Professor of Microbiology and Immunology

Rm. W-704
Tel: (212) 746-4976
Fax: (212) 746-4028

Antigenic variation by malaria parasites

Recent Publications

Here is a sample of recent papers from our faculty.

Go there Now

Programs of Study

Learn more about our academic opportunities.

Go there Now

News And Updates

Prestigious MERIT Grant Funds Research on How the Immune System Can Banish HIV

Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control,...

NIH Funds Consortium to Accelerate Development of New TB Treatments

A new consortium co-led by Weill Cornell Medicine, has been awarded a five-year, $31 million grant from the National Institutes of Health’s National...

Events

October 5, 2024 - 9:00am

8th International Conference on Immunotherapy Radiotherapy Combinations

The clinical management of cancer is being revolutionized by agents that activate the immune system against the tumor. Nevertheless, many of these therapies benefit only a minority of patients. In this context, radiotherapy is holding great promises to complement immunotherapy in the management of malignant disorders. In particular, radiotherapy can generate an “in situ vaccination” effect that is at the foundation of optimal immune responses against cancer cells. Thus, the clinical potential of combining immunotherapy with radiotherapy is extraordinary. Starting in September 2016, Weill Cornell Medicine and Gustave Roussy Cancer Campus have partnered to establish a joint yearly conference that gathers international experts to present cutting edge findings spanning from basic to translational and clinical research on the subject of “Radiotherapy Immunotherapy Combinations”. The first meeting was held at Gustave Roussy Cancer Campus, and since then locations were alternated between Paris and New York City to best promote the field by facilitating international interactions and collaborations. The number of attendees has been growing steadily since the first edition of the meeting, witnessing a growing interest from a heterogeneous community of basic investigators, translational scientists, and clinicians. The meeting has demonstrated to be an ideal covenant for multidisciplinary exchanges between experts in oncology, radiotherapy, and immunotherapy, facilitating networking, enabling direct interaction of industry with academia, and spurring new collaborations. Educational support from industry sponsors contributed to the travel and housing of around thirty speakers each year, and to travel awards for junior investigators, students, post-docs and fellows. The next meeting at Weill Cornell Medical College in New York City is scheduled October 3-5, 2024. The preliminary meeting program and faculty will be available soon. WCM Employees and Students are allowed free ZOOM admission and should register. They will be sent the link on the day of the conference. Outside members of WCM should register and are required to pay.

February 8, 2021 - 12:00pm

Department Of Microbiology And Immunology Monthly Research In Progress Seminars

Sarah Schrader, MD/PhD
Candidate Nathan Lab
“Perturbation of arginine biosynthesis in mycobacteria elicits  tolerance, persistence, and MIC-shifted resistance to antibiotics with  other targets”

Tingting Li, PhD
Guo Lab
“Gut bacterial transamination impacts host amino acid homeostasis and physiology”

Please email Deidre McIntosh-Brown, dem2017@med.cornell.edu. for ZOOM details.

Meetings will occur from 12:00-1:00 pm on the 2nd Monday of each month from October 12, 2020-July 12, 2021 Via Zoom